Burzynski Research Stock Performance
| BZYR Stock | USD 0.03 0 13.33% |
On a scale of 0 to 100, Burzynski Research holds a performance score of 3. The firm shows a Beta (market volatility) of 5.31, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Burzynski Research will likely underperform. Please check Burzynski Research's information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis , to make a quick decision on whether Burzynski Research's price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Burzynski Research are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively abnormal basic indicators, Burzynski Research reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Burzynski |
Burzynski Research Relative Risk vs. Return Landscape
If you would invest 4.70 in Burzynski Research on November 16, 2025 and sell it today you would lose (2.10) from holding Burzynski Research or give up 44.68% of portfolio value over 90 days. Burzynski Research is currently generating 0.9394% in daily expected returns and assumes 21.0368% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Burzynski, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Burzynski Research Target Price Odds to finish over Current Price
The tendency of Burzynski Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.03 | 90 days | 0.03 | about 80.41 |
Based on a normal probability distribution, the odds of Burzynski Research to move above the current price in 90 days from now is about 80.41 (This Burzynski Research probability density function shows the probability of Burzynski Pink Sheet to fall within a particular range of prices over 90 days) .
Burzynski Research Price Density |
| Price |
Predictive Modules for Burzynski Research
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Burzynski Research. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Burzynski Research's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Burzynski Research Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Burzynski Research is not an exception. The market had few large corrections towards the Burzynski Research's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Burzynski Research, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Burzynski Research within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.54 | |
β | Beta against Dow Jones | 5.31 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.04 |
Burzynski Research Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Burzynski Research for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Burzynski Research can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Burzynski Research is way too risky over 90 days horizon | |
| Burzynski Research has some characteristics of a very speculative penny stock | |
| Burzynski Research appears to be risky and price may revert if volatility continues | |
| The company has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Burzynski Research until it has trouble settling it off, either with new capital or with free cash flow. So, Burzynski Research's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Burzynski Research sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Burzynski to invest in growth at high rates of return. When we think about Burzynski Research's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (976.66 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Burzynski Research currently holds about 1.27 K in cash with (325.1 K) of positive cash flow from operations. | |
| Roughly 81.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Cabaletta Bio to Participate in Guggenheim Emerging Outlook Biotech Summit 2026 - Quiver Quantitative |
Burzynski Research Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Burzynski Pink Sheet often depends not only on the future outlook of the current and potential Burzynski Research's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Burzynski Research's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 131.4 M | |
| Cash And Short Term Investments | 3382.00 |
Burzynski Research Fundamentals Growth
Burzynski Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Burzynski Research, and Burzynski Research fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Burzynski Pink Sheet performance.
| Return On Asset | -127.66 | |||
| Current Valuation | 2.65 M | |||
| Shares Outstanding | 131.45 M | |||
| Price To Earning | (5.25) X | |||
| Price To Book | 2,191 X | |||
| EBITDA | (976.66 K) | |||
| Cash And Equivalents | 1.27 K | |||
| Cash Flow From Operations | (325.1 K) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 4.66 K | |||
| Retained Earnings | (118.04 M) | |||
| Current Liabilities | 110 K | |||
About Burzynski Research Performance
Assessing Burzynski Research's fundamental ratios provides investors with valuable insights into Burzynski Research's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Burzynski Research is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas. Burzynski Research is traded on OTC Exchange in the United States.Things to note about Burzynski Research performance evaluation
Checking the ongoing alerts about Burzynski Research for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Burzynski Research help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Burzynski Research is way too risky over 90 days horizon | |
| Burzynski Research has some characteristics of a very speculative penny stock | |
| Burzynski Research appears to be risky and price may revert if volatility continues | |
| The company has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Burzynski Research until it has trouble settling it off, either with new capital or with free cash flow. So, Burzynski Research's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Burzynski Research sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Burzynski to invest in growth at high rates of return. When we think about Burzynski Research's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (976.66 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Burzynski Research currently holds about 1.27 K in cash with (325.1 K) of positive cash flow from operations. | |
| Roughly 81.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Cabaletta Bio to Participate in Guggenheim Emerging Outlook Biotech Summit 2026 - Quiver Quantitative |
- Analyzing Burzynski Research's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Burzynski Research's stock is overvalued or undervalued compared to its peers.
- Examining Burzynski Research's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Burzynski Research's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Burzynski Research's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Burzynski Research's pink sheet. These opinions can provide insight into Burzynski Research's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Burzynski Pink Sheet Analysis
When running Burzynski Research's price analysis, check to measure Burzynski Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burzynski Research is operating at the current time. Most of Burzynski Research's value examination focuses on studying past and present price action to predict the probability of Burzynski Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burzynski Research's price. Additionally, you may evaluate how the addition of Burzynski Research to your portfolios can decrease your overall portfolio volatility.